[Oxford] The real-world safety of atezolizumab as second-line or later treatment in Japanese patients with non-small-cell lung cancer: a post-marketing surveillance study |
|
This post will be closed automatically in 2026-10-23 07:23
Reward30points
|
post
reply
points
0
30
What Determines Consumer Financial Distress? Place- and Person-Based Factors
30
Changing Boundaries of Participation in European Public Spheres:Reflections on Citizenship and Civil Society
30
The real-world safety of atezolizumab as second-line or later treatment in Japanese patients with non-small-cell lung cancer: a post-marketing surveillance study
30
Changing Boundaries of Participation in European Public Spheres:Reflections on Citizenship and Civil Society
30
Corporate Climate Risk: Measurements and Responses
